Corrigendum : Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion
Copyright © 2024 Aguirre, Goulart, Bank, Dalli and Kocher..
[This corrects the article DOI: 10.3389/fimmu.2023.1248547.].
| Errataetall: |
ErratumFor: Front Immunol. 2023 Nov 16;14:1248547. - PMID 38035115 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Frontiers in immunology - 15(2024) vom: 19., Seite 1353835 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aguirre, Gabriel A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ALOX15 |
|---|
| Anmerkungen: |
Date Revised 20.03.2024 published: Electronic-eCollection ErratumFor: Front Immunol. 2023 Nov 16;14:1248547. - PMID 38035115 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fimmu.2024.1353835 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368227006 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368227006 | ||
| 003 | DE-627 | ||
| 005 | 20240322000036.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240209s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2024.1353835 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1338.xml |
| 035 | |a (DE-627)NLM368227006 | ||
| 035 | |a (NLM)38333216 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Aguirre, Gabriel A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum |b Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumFor: Front Immunol. 2023 Nov 16;14:1248547. - PMID 38035115 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2024 Aguirre, Goulart, Bank, Dalli and Kocher. | ||
| 520 | |a [This corrects the article DOI: 10.3389/fimmu.2023.1248547.] | ||
| 650 | 4 | |a Published Erratum | |
| 650 | 4 | |a ALOX15 | |
| 650 | 4 | |a CAF subtypes | |
| 650 | 4 | |a all-trans retinoic acid | |
| 650 | 4 | |a cancer-associated fibroblast | |
| 650 | 4 | |a lipid mediator | |
| 650 | 4 | |a pancreatic ductal adenocarcinoma | |
| 650 | 4 | |a specialized pro-resolving mediator | |
| 700 | 1 | |a Goulart, Michelle R |e verfasserin |4 aut | |
| 700 | 1 | |a Bank, Barts Pancreas Tissue |e verfasserin |4 aut | |
| 700 | 1 | |a Dalli, Jesmond |e verfasserin |4 aut | |
| 700 | 1 | |a Kocher, Hemant M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d 2010 |g 15(2024) vom: 19., Seite 1353835 |w (DE-627)NLM215811453 |x 1664-3224 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g day:19 |g pages:1353835 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fimmu.2024.1353835 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |b 19 |h 1353835 | ||